Academia
Leverage the world’s largest, up-to-date, longitudinal clinical and claims data to generate real-world evidence.
Bring TriNetX to Your Organization
Research Institute
Utilize real-world data to excel in research. TriNetX is available for department-wide use.
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/11/deptheadsAsset-5@300x.png)
Department Heads
Empower your department with data designed for scientific publications, grant submissions, poster presentations and much more.
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/11/researchAsset-6@300x.png)
Individual Researchers
Download data sets, perform advanced analyses for grant submissions, manuscript and poster submissions, and collaborate with like-minded researchers.
Classroom
Discover the power of data in the classroom; students and educators can iterate quickly using TriNetX, reaching real-time answers without the need for time-intensive statistical platforms.
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/11/teachersAsset-7@300x.png)
Teachers
Communicate complex, advanced analyses to students using real data in real time. Provide students with a powerful tool to answer their clinical questions.
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/11/studentsAsset-8@300x.png)
Students
Access data for dissertation and manuscript development. Explore EMR and claims data to learn more about target populations, compare drug effectiveness, assess real-world drug performance and much more.
Global Breadth. Unprecedented Depth. All Therapeutic Areas.
Top Therapeutic Areas
Sample Indication Counts
-
1,003 Neuroblastoma (aged <10)
-
2,571 Triple Negative Breast Cancer
-
34,183 Histology Confirmed NSCLC
-
109,412 Crohn’s Disease
-
462,422 Pediatric Asthma
Data Characteristics
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/11/map-monthly.png)
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/11/sources-1.png)
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/11/breadth.png)
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/11/depth-1.png)
Benefits
-
Research-ready EMR data
-
All therapeutic areas
-
Comprehensive pediatric data
-
Inpatient/outpatient
-
Data curated, standardized and mapped to common data models
-
Generate replicable, generalized results
-
Detailed insight into rare diseases
-
Reduce selection bias with data sourced from diverse sites
-
Explore patient cohorts to discover comorbidities and confounders
-
Create your most accurate cohorts using temporal events, disease milestones, and in-depth medication details
![](https://open.tnxdev.com/wp-content/uploads/sites/2/2019/10/boxworldAsset-3-1.png)
Publications Using TriNetX
Masurkar P., Rege S., & Aparasu R.R. (2019) ND4 Comparison Of TriNetX Electronic Medical Record Database And National Ambulatory Medical Care Survey: Findings On The Inappropriate Medications Use In Parkinson’s Disease In The United States. Value in Health, Vol. 22, S43. doi: https://doi.org/10.1016/j.jval.2019.04.062
Buysse B., & Albano J. (2019.) A Snapshot of Characteristics Recorded in Electronic Medical Records of Women with Polycystic Ovary Syndrome in TriNetX Within Two Years of Diagnosis. Syneos Health Morrisville, NC, USA; 2. Syneos Health, Farnborough, UK. 35th ICPE, Philadelphia, PA, 26 Aug 2019
Stacey, J., Lovestone, S., Harrison, P., Denis, M., Nevado-Holgado, A., & Newby, D. (2018). PND2 – Risk of Parkinson’s Disease (PD) in Patients Taking Adrenergic Drug Treatments. Value in Health, Vol. 21, S329. doi: https://doi.org/10.1016/j.jval.2018.09.1969
Martin, C. A., Burgess, D. R., Wallace, K. L., Vanhoose, J., Cotner, S., & Burgess, D. S. (2018). 1026. Trends in Infective Endocarditis During the Substance Use Disorder Epidemic at an Academic Medical Center. Open Forum Infectious Diseases, 5(Suppl 1), S306. doi:10.1093/ofid/ofy210.863
Kolodney, J.A., Kolodney, M., Pattersion, J., Hagen, R., Smolkin, M., Hobbs., G., Hogan, T., Hafex, M., & Albandar, H. (2019). A study of tobacco abuse as a risk factor for adrenal cortical carcinoma. Journal of Clinical Oncology 37, no. 15_suppl. doi:10.1200/JCO.2019.37.15_suppl.e16119
Acharya, M., & Painter, J. (2018). New Oral Anticoagulants And The Risk Of Vasculitis: A Nested Case-Control Study. Value in Health, Vol. 21, S55. doi: https://doi.org/10.1016/j.jval.2018.04.324